Asia Pacific Legal Cannabis Market size is expected to be valuated at USD 140.0 Billion by 2035; The Market can be driven by Shifting Public Perception and Reduced Stigma

Download Sample

Published Date: July 2025

Legal cannabis provides medicinal advantages including pain alleviation, less dependence on opioids, and promotes controlled, transparent markets. It is authorized for medical or recreational use under national laws. The market is growing quickly in the Asia Pacific area due to increased government backing, growing knowledge of the health advantages, and growing demand for wellness products based on CBD, particularly among younger, urban populations. With encouraging laws, research funding, and pharmaceutical-grade development, nations such as South Korea, Thailand, and Australia are setting the standard.

Segmentation Analysis:

By Product Type	Flower Buds, Concentrates, Edibles, Oil & Tinctures, Topicals, and Others
By Source	Marijuana, and Hemp
By Species	Cannabis Sativa, Cannabis Indica, and Cannabis Ruderalis
By End User	Patients, Adult Consumers, Pharmaceutical Companies, Research Institutes, Beauty & Personal Care Industry, and Others

Report Highlights:

Asia Pacific legal cannabis market size is valuated at USD 17.0 Billion in 2025.
Target market size is estimated to be valuated at USD 140.0 Billion by 2035 and at a CAGR of 23.71%.
Oil and tinctures hold the most Asia-Pacific legal cannabis market share on account of product type.
Hemp-derived products have the largest Asia Pacific legal cannabis market share.
By species, Cannabis sativa has the most Asia Pacific legal cannabis market share.
By end user, Patients make up the largest end-user sector in the Asia-Pacific legal cannabis market size.
China presently holds the top spot in the Asia-Pacific legal cannabis market growth.

Market Dynamics:

Growing Factor

Challenge Factor

Market Trend

Significant Investments in Cultivation, R&D, And Pharmaceutical-Grade Cannabis Production

Inconsistent Regulations Across Countries

Expansion of Telemedicine and Digital Healthcare Platforms

Key Highlights:

In August 2020, to acquire 6.6% of Australia-based Altum International Pty Ltd, one of the top cannabinoid platforms in Asia-Pacific, Village Farms International, Inc. announced that it has signed a legally binding agreement, subject to the fulfillment of specific requirements that should be completed in the coming weeks. In accordance with the Agreement, Village Farms may choose to raise its Altum shareholding on comparable conditions.

Report Analysis:

Effects of Legalizing Cannabis:

Legalization has a number of broad ramifications, including as better access to safe and regulated goods for both medical and recreational users, less strain on the legal and law enforcement systems, and the emergence of a new legal sector that creates jobs and tax income. Additionally, it promotes scientific research into cannabis-based cures, improves product quality and customer safety through regulations and testing, and reduces illicit commerce by rerouting demand to regulated marketplaces. Legalization raises significant public health and regulatory issues while also having the social potential to lessen stigma and encourage responsible, educated usage.

Browse ∼40 market data tables and ∼35 figures through ∼140 slides and in-depth TOC on “Asia Pacific Legal Cannabis Market, By Product Type (Flower Buds, Concentrates, Edibles, Oil & Tinctures, Topicals, and Others), Source (Marijuana, and Hemp), Species (Cannabis Sativa, Cannabis Indica, and Cannabis Ruderalis), End-User (Patients, Adult Consumers, Pharmaceutical Companies, Research Institutes, Beauty & Personal Care Industry, and Others), and Country - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Product Type:

Flower Buds
Concentrates
Edibles
Oil & Tinctures
Topicals
Others

By Source:

Marijuana
Hemp

By Species:

Cannabis Sativa
Cannabis Indica
Cannabis Ruderalis

By End User:

Patients
Adult Consumers
Research Institutes
Beauty & Personal Care Industry
Others

By Country:

China
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia-Pacific

For more insights into the Asia Pacific Legal Cannabis Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/asia-pacific-legal-cannabis-market-5951

Competitive Landscape of Asia Pacific Legal Cannabis Market:

The key players operating in the Asia Pacific legal cannabis market include Little Green Pharma, Cann Group Limited, Vitura Health Limited, ECS Botanics, Amber Farm Co., Ltd., Tenrain Co., Ltd., Cannavedic, Hempstrol, HEMPTHAI, CannaMeds India, Aarogya CBD, Inspire Fitness, PANAXIA, and Cannapure Pvt. Ltd.